Who will present for ASP Isotopes at the Canaccord Genuity conference, and what is the timing and focus of the presentation?

ASP Isotopes' Chief Commercial Officer, Viktor Petkov, will present at Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026, at 8:00 a.m. ET; the presentation will focus on the company's proprietary Aerodynamic Separation Process and Quantum Enrichment technologies.

What merger-related developments did ASP Isotopes announce alongside its conference presentation?

ASP Isotopes announced proposed merger transactions involving ENDRA Life Sciences, Renergen, and Noble Africa, and noted that ENDRA plans to file a Form S-4 registration statement.

ASP Isotopes to Webcast Aug. 12 Presentation on Technologies and Merger Plans

Jul 30, 2026

ASP Isotopes announced a live webcast of its Chief Commercial Officer's presentation at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. The session will detail proprietary separation technologies and proposed merger transactions involving ENDRA Life Sciences.

Stock Titan

2026-03-31

ASP Isotopes Partners with University of Bristol, Survives Class-Action Lawsuit

2026-04-11

ASP Isotopes Inc Targets Initial Commercial Shipments for Key Isotopes by 2026-2027

2026-04-12

ASP Isotopes Revenue Surge Tests Bullish Growth Narratives Against Deepening Losses

2026-04-13

ASP Isotopes Reports Q4 Revenue Surge Amid Widening Losses

2026-04-13

$333M Cash Backs ASP Isotopes' 2026 Push for First Sales